Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy

PURPOSE: Previous studies have shown an increased risk of second primary malignancies (SPMs) in survivors of diffuse large B-cell lymphoma (DLBCL). Survivors live longer due to the intensification of and improvements in therapy; thus, we aimed to characterize SPM patterns in patients with DLBCL by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rock, Calvin B., Chipman, Jonathan J., Parsons, Matthew W., Weil, Chris R., Hutten, Ryan J., Tao, Randa, Tward, Jonathan D., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Gaffney, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677201/
https://www.ncbi.nlm.nih.gov/pubmed/36420188
http://dx.doi.org/10.1016/j.adro.2022.101035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677201/
https://www.ncbi.nlm.nih.gov/pubmed/36420188
http://dx.doi.org/10.1016/j.adro.2022.101035

Ejemplares similares